OLD Category: immuno-oncology
November 15, 2014 / Clin. Cancer Res.
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
October 12, 2014 / Pediatric Blood and Cancer
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children’s Oncology Group
February 12, 2014 / Journal of Investigative Dermatology
Dissection of immune gene networks in primary melanoma tumors critical for anti-tumor surveillance of patients with stage II-III resectable disease
November 22, 2013 / Science
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment
October 8, 2013 / JCI
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
September 10, 2013 / Clin. Can. Res.
Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
August 8, 2013 / Oncogene
Immunobiology of human mucin 1 in a preclinical ovarian tumor model
July 15, 2013 / International Journal of Cancer
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer
April 1, 2013 / OncoImmunology
TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
February 14, 2013 / J of Immunother